Answers are grounded in this paper and cite their sources.
In vitro study demonstrates enhanced cell entry and antibody evasion by H3N2 subclade K, indicating that existing vaccines still boost protection.
In 2025, a mutated H3N2 lineage, subclade K, emerged, showing high activity in many regions. Mutations in the hemagglutinin (HA) may affect cell entry and antibody-mediated neutralisation. Using pseudovirus particles, we show that subclade K-HA drives augmented entry into certain cell lines and displays significant antibody evasion. Both phenotypes were linked to mutation A186D. Influenza vaccination significantly boosted H3N2 subclade K neutralisation, suggesting that current vaccines may provide considerable protection.
No takes yet. Share an insight, caveat, or question.
Moor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: